Blink detection and magnetic force generation for correction of lagophthalmos, with specific regard to implant compatibility testing.


Journal

Orbit (Amsterdam, Netherlands)
ISSN: 1744-5108
Titre abrégé: Orbit
Pays: England
ID NLM: 8301221

Informations de publication

Date de publication:
Feb 2022
Historique:
pubmed: 6 10 2020
medline: 3 2 2022
entrez: 5 10 2020
Statut: ppublish

Résumé

The overall goal was to restore a normal and synchronous blink in unilateral lagophthalmos. We describe the biocompatibility profiling of a novel ferromagnetic implant used for electromagnetic eyelid force generation. A non-contact blink detection system and an electromagnetic stimulation system were designed and tested. A modified Lester-Burch speculum equipped with strain gauge technology was used in blinking force measurement. Samarium-cobalt magnets were prototyped and coated with parylene-C. Biocompatibility testing was performed using NIH/3T3 mouse fibroblast cells with MTT colorimetric assay cytotoxic quantification. Cellular viability and interleukin concentrations. Our system was capable of detecting 95.5 ± 3.6% of blinks in various lighting conditions. Using our force measuring device, the difference between non-paralyzed and paralyzed orbicularis oculi (OO) for normal and forceful blinking closure was 40.4 g and 101.9 g, respectively. A 16.6 × 5.0 × 1.5 mm curved shaped samarium cobalt eyelid implant was successfully developed and showed a reproducible blink at 100 ms with full corneal coverage with external eyelid taping. Compared to gold weights, parylene-C coated samarium cobalt implants showed not only excellent cell viability (82.0 ± 4.9% vs. 88.4 ± 0.9%, respectively, We demonstrated excellent

Identifiants

pubmed: 33016160
doi: 10.1080/01676830.2020.1826544
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

59-68

Auteurs

Razek Georges Coussa (RG)

Department of Ophthalmology and Visual Sciences, Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA.
Department of Ophthalmology and Visual Sciences, McGill University Health Center, Montreal, Quebec, Canada.
Biomedical Technology and Cell Therapy Research Laboratory, Department of Biomedical Engineering, McGill University, Montreal, Quebec, Canada.

Nikita Lomis (N)

Biomedical Technology and Cell Therapy Research Laboratory, Department of Biomedical Engineering, McGill University, Montreal, Quebec, Canada.

Fares Antaki (F)

Department of Ophthalmology and Visual Sciences, McGill University Health Center, Montreal, Quebec, Canada.
Department of Ophthalmology, Université De Montréal, Montreal, Quebec, Canada.

Jason Samle (J)

Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, Ontario, Canada.

Kavita Patel (K)

Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, Ontario, Canada.

George Christodoulou (G)

Department of Dermatology, McGill University Health Center, Montreal, Canada.

Satya Prakash (S)

Biomedical Technology and Cell Therapy Research Laboratory, Department of Biomedical Engineering, McGill University, Montreal, Quebec, Canada.

James Oestreicher (J)

Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, Ontario, Canada.

Bryan Arthurs (B)

Department of Ophthalmology and Visual Sciences, McGill University Health Center, Montreal, Quebec, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH